Brief: Neuland Laboratories Says NCLT Approved Scheme Of Amalgamation Between Co, Neuland Health Sciences, Neuland Pharma Research
March 28 (Reuters) - Neuland Laboratories Ltd NEUL.NS :
* NCLT, HYDERABAD BENCH, APPROVED SCHEME OF AMALGAMATION
BETWEEN
CO, NEULAND HEALTH SCIENCES, NEULAND PHARMA RESEARCH
Source text - http://bit.ly/2pMc2jy
Further company coverage: NEUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuland Laboratories
See all newsIndia's Neuland Laboratories jumps after approving $13.3 mln land purchase for expansion
Brief: Neuland Laboratories Approves Capital Expenditure Of 1.26 Billion Rupees For Land Purchase In Kakinada
Brief: Neuland Laboratories Says US FDA Inspects Neuland Laboratories Unit 3 From August 10 To 14, 2026
Brief: Neuland Laboratories June-Quarter Consol Profit 1.48 Billion Rupees
Brief: Neuland Laboratories March-Quarter Consol Profit 2.13 Bln Rupees